Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient.
AFIAS Free Anti-Adalimumab can detect the presence of anti-drug antibodies against
Adalimumab, requiring only a small amount of human serum or whole blood,
and delivering results in a mere 12 minutes. This allows physicians to verify the
presence of anti-drug antibodies immediately before the next administration.
Reagents, Therapeutic Drug Monitoring
Free Anti-Adalimumab
Detecting the development of Anti-drug antibodies (ADAs) against Adalimumab in patients being treated with Adalimumab for chronic autoimmune and inflammatory conditions
Reviews
There are no reviews yet.